Enhancing the role of vaccines in combatting antimicrobial resistance

Vaccine

Volumn 35, Issue 48, 2017, Pages 6591-6593

  Clift, Charles ^a   Salisbury, David M ^a  

^a ROYAL INSTITUTE OF INTERNATIONAL AFFAIRS   (United Kingdom)

Author keywords

Antibiotics; Antimicrobial resistance; Vaccines; Valuation

Indexed keywords

ANTIBIOTIC AGENT; MENINGOCOCCUS VACCINE; RESPIRATORY SYNCYTIAL VIRUS VACCINE; VACCINE; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; COST EFFECTIVENESS ANALYSIS; DRUG RESEARCH; GONORRHEA; GROUP B STREPTOCOCCAL INFECTION; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; INFLUENZA; MENINGOCOCCEMIA; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL VIRUS INFECTION; TUBERCULOSIS; TYPHOID FEVER; VACCINATION; VACCINE PRODUCTION; COMMUNICABLE DISEASE; COMMUNICABLE DISEASE CONTROL; LEGISLATION AND JURISPRUDENCE; MICROBIOLOGY; PROCEDURES;

ANTI-BACTERIAL AGENTS; COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES; DRUG RESISTANCE, BACTERIAL; GONORRHEA; HUMANS; TUBERCULOSIS; VACCINES;

EID: 85034077858     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2017.09.053     Document Type: Article

References (12)

1. Boston Consulting Group, Federal Ministry of Health. Breaking through the Wall: a call for concerted action on antibiotics research and development. Berlin; 2017. < http://www.bcg.de/documents/file219507.pdf>.
2. Review on Antimicrobial Resistance. Tackling drug-resistant infections globally: final report and recommendations. London; 2016. < https://amr-review.org/sites/default/files/160525_Final%20paper_with%20cover.pdf>.
3. Review on Antimicrobial Resistance. Vaccines and alternative approaches: reducing our dependence on antimicrobials. London; 2016. < https://amr-review.org/sites/default/files/Vaccines%20and%20alternatives_v4_LR.pdf>.
4. Chatham House. Meeting summary: the value of vaccines in the avoidance of antimicrobial resistance. London; 2017. https://www.chathamhouse.org/sites/files/chathamhouse/events/2017-03-30-amr-vaccines-meeting-summary.pdf.
5. Tomczyk, S., et al. Prevention of antibiotic-nonsusceptible invasive pneumococcal disease with the 13-valent pneumococcal conjugate vaccine. Clin Infect Dis 62:9 (2016), 1119–1125.
6. von Gottberg, A., et al. Effects of vaccination on invasive pneumococcal disease in South Africa. New Engl J Med 371 (2014), 1889–1899.
7. Fleming-Dutra, K.E., et al. Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits, 2010–2011. JAMA 315:17 (2016), 1864–1873.
8. Kwong, J.C., et al. The effect of universal influenza immunization on antibiotic prescriptions: an ecological study. Clin Infect Dis 49:5 (2009), 750–756.
9. Shrestha, K.L., et al. Re-emergence of the susceptibility of the Salmonella spp. isolated from blood samples to conventional first line antibiotics. Antimicrobial Resist Infect Control, 5, 2016, 22.
10. H. Petousis-Harris et al. Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand – a retrospective case control study Lancet 2017. https://doi.org/10.1016/S0140-6736(17)31449-6.
11. World Health Organization. WHO publishes list of bacteria for which new antibiotics are urgently needed. Press release. Geneva; February 2017. < http://www.who.int/mediacentre/news/releases/2017/bacteria-antibiotics-needed/en/>.
12. Review on Antimicrobial Resistance. Antimicrobials in agriculture and the environment: reducing unnecessary use and waste. London; 2015. < https://amr-review.org/sites/default/files/Antimicrobials%20in%20agriculture%20and%20the%20environment%20-%20Reducing%20unnecessary%20use%20and%20waste.pdf>.